ArticleHereditas2025
Global research trends and emerging focus areas in IgG4-related disease: a bibliometric and visual analysis.
Article in Hereditas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImmunoglobulin G4-related disease (IgG4-RD) is a systemic autoimmune condition marked by fibroinflammatory infiltration, which may present as solitary or multiple masses and organ enlargement. In advanced stages, progression to multi-organ dysfunction or failure may occur, potentially resulting in mortality. This study aimed to examine the current status and evolving research trends in IgG4-RD from 2020 to 2024 through bibliometric and visualization methodologies.
methodA total of 1,084 English-language publications on IgG4-RD, dated from January 1, 2020, to October 22, 2024, were retrieved from the Web of Science Core Collection. Bibliometric and visual analyses were performed using VOSviewer and CiteSpace software to identify research trends, collaborative networks, and thematic developments.
resultsThe analysis included 1,084 publications, reflecting sustained research activity in the field over the examined period. The Chinese Academy of Medical Sciences & Peking Union Medical College accounted for the greatest number of publications. Among individual contributors, Wen Zhang was identified as the most prolific author. In terms of national output, China led in publication volume, whereas Japan exhibited the highest total citation frequency. Internal Medicine published the greatest number of articles, while Modern Rheumatology had the highest citation rate. Keyword co-occurrence analysis revealed prominent research themes, including "IgG4-related disease," "autoimmune pancreatitis," "case report," "Rituximab," and "Diagnosis."
conclusionThe global research output on IgG4-RD has demonstrated notable growth in recent years. Further investigations focusing on the emerging thematic areas may yield valuable insights that can enhance clinical diagnosis and therapeutic approaches for individuals affected by IgG4-RD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.